Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Author Profile Past 90 Days 71 stories 1 Publishers

frank vinluan

No author bio on file yet.

Social profiles not yet on file.
frank vinluan's Coverage
Buzz
Media Coverage
World View
Beat Reporting
Category Articles Share
Health_Medical_Pharma 65
Business_Finance 6

GSK Pays $110M for Phase 1-Ready Hutchmed Asset in a New Class of Cancer Drugs
2026-09-07 — medcitynews.com


FDA Approves Ionis Pharma Drug, the First for Ultra-Rare Alexander Disease
2026-09-04 — medcitynews.com


Ultragenyx Trial Failure Revives Debate About How to Treat a Rare Neuro Disorder
2026-09-03 — medcitynews.com


Teva Drug Rises to the Gluten Challenge, Stopping Intestinal Damage in Celiac Disease Trial
2026-09-02 — medcitynews.com


GSK’s Pivotal Test for mRNA Flu Vaccine Aims to Show Two Targets Are Better Than One
2026-09-01 — medcitynews.com


First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder
2026-08-31 — medcitynews.com


SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven
2026-08-30 — medcitynews.com


FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant’s Biz Strategy
2026-08-28 — medcitynews.com


AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New Indication
2026-08-27 — medcitynews.com


Revolution Medicines Receives Landmark FDA Drug Approval in Pancreatic Cancer
2026-08-26 — medcitynews.com

Execution: 0.16 Seconds. 52.11 mb used.